Evaluation of iron deposition in the motor CSTC loop of a Chinese family with paroxysmal kinesigenic dyskinesia using quantitative susceptibility mapping

Introduction Previous studies have revealed structural, functional, and metabolic changes in brain regions inside the cortico-striatal-thalamo-cortical (CSTC) loop in patients with paroxysmal kinesigenic dyskinesia (PKD), whereas no quantitative susceptibility mapping (QSM)-related studies have explored brain iron deposition in these areas. Methods A total of eight familial PKD patients and 10 of their healthy family members (normal controls) were recruited and underwent QSM on a 3T magnetic resonance imaging system. Magnetic susceptibility maps were reconstructed using a multi-scale dipole inversion algorithm. Thereafter, we specifically analyzed changes in local mean susceptibility values in cortical regions and subcortical nuclei inside the motor CSTC loop. Results Compared with normal controls, PKD patients had altered brain iron levels. In the cortical gray matter area involved with the motor CSTC loop, susceptibility values were generally elevated, especially in the bilateral M1 and PMv regions. In the subcortical nuclei regions involved with the motor CSTC loop, susceptibility values were generally lower, especially in the bilateral substantia nigra regions. Conclusion Our results provide new evidence for the neuropathogenesis of PKD and suggest that an imbalance in brain iron levels may play a role in PKD.

[1]  Hongjiang Wei,et al.  APART-QSM: An improved sub-voxel quantitative susceptibility mapping for susceptibility source separation using an iterative data fitting method , 2023, NeuroImage.

[2]  B. Tang,et al.  TMEM151A Variants Cause Paroxysmal Kinesigenic Dyskinesia: A Large‐Sample Study , 2021, Movement disorders : official journal of the Movement Disorder Society.

[3]  D. Attwell,et al.  Astrocyte Ca2+-evoked ATP release regulates myelinated axon excitability and conduction speed , 2021, Science.

[4]  Z. Xiong,et al.  Cerebellar spreading depolarization mediates paroxysmal movement disorder. , 2021, Cell reports.

[5]  Nan-Jie Gong,et al.  Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data , 2021, NeuroImage.

[6]  J. D. Mills,et al.  Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy , 2021, Acta Neuropathologica.

[7]  D. Garcia-Borreguero,et al.  Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome. , 2021, Sleep Medicine.

[8]  Yuxiang cai,et al.  Ferroptosis and Its Role in Epilepsy , 2021, Frontiers in Cellular Neuroscience.

[9]  M. Zhang,et al.  Brainstem Involvement in Amyotrophic Lateral Sclerosis: A Combined Structural and Diffusion Tensor MRI Analysis , 2021, Frontiers in Neuroscience.

[10]  B. Xiao,et al.  Novel PRRT2 gene variants identified in paroxysmal kinesigenic dyskinesia and benign familial infantile epilepsy in Chinese families , 2021, Experimental and Therapeutic Medicine.

[11]  Zhaoxia Wang,et al.  Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China , 2021, Translational Neurodegeneration.

[12]  Qifu Li,et al.  Iron Metabolism and Ferroptosis in Epilepsy , 2020, Frontiers in Neuroscience.

[13]  Guangxiang Chen,et al.  Neural Mechanisms of Paroxysmal Kinesigenic Dyskinesia: Insights from Neuroimaging , 2020, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[14]  A. Lees,et al.  Brain iron deposition is linked with cognitive severity in Parkinson’s disease , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  Dong Zhou,et al.  Altered topological organization of functional brain networks in drug-naive patients with paroxysmal kinesigenic dyskinesia , 2020, Journal of the Neurological Sciences.

[16]  Nellie Georgiou-Karistianis,et al.  Altered Cortical Morphometry in Pre-manifest Huntington’s Disease: Cross-sectional Data from the IMAGE-HD Study , 2019, 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[17]  Qiqi Chen,et al.  Iron deposition in Parkinson’s disease by quantitative susceptibility mapping , 2019, BMC Neuroscience.

[18]  Euan A Ashley,et al.  Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy , 2019, PloS one.

[19]  Oliver Speck,et al.  A robust multi-scale approach to quantitative susceptibility mapping , 2018, NeuroImage.

[20]  Chunlei Liu,et al.  Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping , 2018, NeuroImage.

[21]  Yang Li,et al.  PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum , 2017, Cell Research.

[22]  Nian Wang,et al.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.

[23]  Huafu Chen,et al.  Thalamocortical dysconnectivity in paroxysmal kinesigenic dyskinesia: Combining functional magnetic resonance imaging and diffusion tensor imaging , 2017, Movement disorders : official journal of the Movement Disorder Society.

[24]  Yi Wang,et al.  The clinical utility of QSM: disease diagnosis, medical management, and surgical planning , 2017, NMR in biomedicine.

[25]  C. Achat-Mendes,et al.  Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator , 2017, Neural regeneration research.

[26]  Thomas Walker,et al.  Dissociation between iron accumulation and ferritin upregulation in the aged substantia nigra: attenuation by dietary restriction , 2016, Aging.

[27]  P. V. van Zijl,et al.  Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease , 2016, American Journal of Neuroradiology.

[28]  Julio Acosta-Cabronero,et al.  In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan , 2016, The Journal of Neuroscience.

[29]  B. Tang,et al.  Paroxysmal kinesigenic dyskinesia , 2015, Neurology.

[30]  Julie C Stout,et al.  Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  Dong-Wook Kim,et al.  Thalamic involvement in paroxysmal kinesigenic dyskinesia: A combined structural and diffusion tensor MRI analysis , 2015, Human brain mapping.

[32]  N. J. Allen,et al.  Astrocyte regulation of synaptic behavior. , 2014, Annual review of cell and developmental biology.

[33]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.

[34]  Robert Turner,et al.  Myelin and iron concentration in the human brain: A quantitative study of MRI contrast , 2014, NeuroImage.

[35]  A. Lees,et al.  Clinical features of childhood‐onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations , 2013, Developmental medicine and child neurology.

[36]  Q. Gong,et al.  Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation , 2013, Neurological Sciences.

[37]  A. Leemans,et al.  Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes , 2012, Diabetes Care.

[38]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[39]  Ning Wang,et al.  Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia , 2011, Nature Genetics.

[40]  Mark Hallett,et al.  Definition and classification of hyperkinetic movements in childhood , 2010, Movement disorders : official journal of the Movement Disorder Society.

[41]  Hehan Tang,et al.  Hyperactive putamen in patients with paroxysmal kinesigenic choreoathetosis: A resting‐state functional magnetic resonance imaging study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[42]  Hehan Tang,et al.  The thalamic ultrastructural abnormalities in paroxysmal kinesigenic choreoathetosis: a diffusion tensor imaging study , 2010, Journal of Neurology.

[43]  J. Connor,et al.  Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.

[44]  F. Schmidt Meta-Analysis , 2008 .

[45]  Daniel M. Corcos,et al.  Three-dimensional locations and boundaries of motor and premotor cortices as defined by functional brain imaging: A meta-analysis , 2006, NeuroImage.

[46]  J. Connor,et al.  Iron status and neural functioning. , 2003, Annual review of nutrition.

[47]  H. Matsuda,et al.  Increased ictal perfusion of the thalamus in paroxysmal kinesigenic dyskinesia , 2001, Journal of neurology, neurosurgery, and psychiatry.

[48]  J. Connor,et al.  Iron and iron management proteins in neurobiology. , 2001, Pediatric neurology.

[49]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[50]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[51]  Yan-zhong Chang,et al.  Brain Iron Metabolism and CNS Diseases. , 2019, Advances in experimental medicine and biology.

[52]  Fudi Wang,et al.  Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. , 2010, Future medicinal chemistry.